Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.242
H.R.242: Medicare Prescription Drug Price Negotiation Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced Jan. 4, 2017
- Latest Major Action Jan. 25, 2017
- See the six similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
45 (44 Democrats, 1 Republican)
Bill Version
- Introduced in House - Jan. 4, 2017
Bill Summary
Medicare Prescription Drug Price Negotiation Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Jan. 25, 2017 |
Referred to the Subcommittee on Health.
|
Jan. 13, 2017 |
Referred to the Subcommittee on Health.
|
Jan. 4, 2017 |
Referred to House Ways and Means
|
Jan. 4, 2017 |
Referred to House Energy and Commerce
|
Jan. 4, 2017 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Jan. 4, 2017 |
Introduced in the House by Peter Welch (D-Vt.) |